Glaucoma News

ChatGPT correctly and satisfactorily answered nine out of 10 frequently asked questions about glaucoma concerning general information, diagnosis, treatment and prevention, according to an analysis published in Journal of Glaucoma.

An educational training program in the U.K. enabled non-MD ophthalmic practitioners to safely and effectively deliver selective laser trabeculoplasty to patients with glaucoma, according to a study published in Eye.

While most children with glaucoma have at least one visual field test per year, Black and multiracial children were among those with significantly lower testing frequency, according to a single-center study published in Journal of Glaucoma.

In this Healio Video Perspective from the ASRS meeting, Jordana G. Fein, MD, MS, of Retina Group of Washington discusses IOP outcomes in patients with diabetic macular edema who were treated with aflibercept 8 mg or aflibercept 2 mg.

Eighteen medications appeared to be associated with angle-closure glaucoma, including sulfonamides, serotonergic agents and antimuscarinic agents, according to a retrospective analysis published in Ophthalmology Glaucoma.

Healio’s recent stories in glaucoma include the de novo classification of an ocular pressure adjusting pump and promising results with timolol microdrops to lower IOP.

Alcon completed the acquisition of Belkin Vision, including its direct selective laser trabeculoplasty technology, according to a press release.

As a past president of the Pennsylvania Optometric Association, I am very familiar with how our profession expands its scope of practice.

The FDA granted de novo classification to the Fysx ocular pressure adjusting pump for patients with normal-tension glaucoma or open-angle glaucoma with IOP of 21 mm Hg or less, according to a press release from Balance Ophthalmics.

NASHVILLE, Tenn. — Alcon’s U.S. pharmaceutical division shared its focus on glaucoma and dry eye with attendees at Optometry’s Meeting.